Regulatory Crackdown on PE in Healthcare Intensifies
Key Questions
What actions have major medical organizations taken against private equity in healthcare?
The ACP and AMA have formalized their opposition to private equity involvement in healthcare. This reflects growing concerns over impacts on patient care and professional standards.
Which states are introducing legislation to regulate private equity deals in healthcare?
Bills in Pennsylvania (PA HB1460), California, Connecticut, Maine, and Vermont aim to tighten pre-deal reviews for private equity transactions. These measures seek to increase scrutiny and protect healthcare operations.
What is the California Attorney General's lawsuit against Carbon Health and Aspen Dental about?
The suit alleges improper MSO control and seeks penalties exceeding $6 million. It highlights regulatory efforts to curb private equity influence over clinical practices.
How are CMS proposed rules affecting healthcare providers?
The rules include cuts to 340B payments, expanded site-neutral imaging, bans on third-party RPM vendors, and a 20% reduction in joint replacement reimbursements. These changes increase operational pressures and may accelerate consolidation among multi-site providers.
What happened in the Valley Health outsourcing controversy?
Valley Health defended its decision to outsource to PE-backed SCP Health despite warnings from a clinician coalition about risks to patient care. The incident underscores rising reputational risks for PE-backed healthcare arrangements.
Major medical organizations (ACP, AMA) formalized opposition to PE; state bills (PA HB1460, CA/CT/ME/VT) tighten pre-deal review; California AG sues Carbon Health and Aspen Dental over MSO control with $6M+ penalties. CMS proposed rules cut 340B payments, expand site-neutral imaging, ban third-party RPM vendors, and reduce joint replacement reimbursement by 20%—all driving consolidation and operational pressure on multi-site healthcare CEOs. Recent articles provide analysis on RVU valuation changes for joint arthroplasty and a framework for site-neutral payment strategy. A Valley Health story in Virginia shows PE-backed outsourcing (SCP Health) defended against clinician coalition, adding to the reputational risk landscape. Q2 earnings signals from UHG, Elevance, HCA add payer behavior context. A Keckley piece highlights physician outlook clouded by CMS cuts, AI billing disputes, and 80% employment by systems/PE. A physician's personal account of leaving PE and returning to private practice reinforces the value of autonomy and the risk of price inflation without quality gains.